Biological factors that place women at risk for HIV: evidence from a large-scale clinical trial in Durban

被引:19
|
作者
Abbai, Nathlee Samantha [1 ]
Wand, Handan [3 ]
Ramjee, Gita [1 ,2 ]
机构
[1] MRC, HIV Prevent Res Unit, 123 Jan Hofmeyr Rd, ZA-3630 Durban, South Africa
[2] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England
[3] Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia
来源
BMC WOMENS HEALTH | 2016年 / 16卷
关键词
HIV infection; Epithelial disruption; Abnormal vaginal discharge; Sexually transmitted infections; HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED INFECTIONS; GENITAL ULCER DISEASE; TRACT; TRANSMISSION; ASSOCIATION; ACQUISITION; EXPRESSION; GEL;
D O I
10.1186/s12905-016-0295-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: It is well documented that the mucosal linings of the female genital tract (FGT) usually provides a robust barrier that protects against sexually acquired infections. However, to the best of our knowledge there are limited South African studies that have investigated the association between damage to the mucosal linings and the acquisition of HIV infections. We hypothesize that in this cohort of women, a higher rate of HIV seroconversions will be observed for women who present with evidence of mucosal damage. Methods: We undertook a secondary analysis of the Methods for Improving Reproductive Health in Africa (MIRA) trial that assessed the effectiveness of the latex diaphragm and lubricant gel on HIV prevention among women. Participants underwent a physical examination which included a pelvic examination to detect the presence of mucosal abnormalities. During the physical examinations, the study clinicians examined the genitalia, cervix and vagina for signs of epithelial disruptions and abnormal vaginal discharge. The association between the various genital factors and HIV seroconversion was modeled using Cox proportional hazards regression analysis. Results: In this cohort of 1485 women that had enrolled to participate in the study, women that had presented with genital epithelial disruptions and abnormal vaginal discharge were shown to be at highest risk for HIV acquisition (Hazard Ratio (HR): 4.30, 95 % CI: 2.25, 8.22, p < 0001, HR: 2.37, 95 % CI: 1.69, 3.33, p < 0.001) respectively. In addition, the Kaplan Meier analysis showed that the highest number of seroconversions was observed in women that had disrupted genital epithelia (27 per 100/py, 95 % CI: 15.0, 50.7) and abnormal vaginal discharge (12 per 100/py, 95 % CI: 9.70, 16.7). Other significant factors included: genital signs and symptoms (HR: 1.67, 95 % CI: 1.07, 2.61, p = 0.02) and genital ulcers/sores (HR: 1.79, 95 % CI: 1.05, 3.06, p = 0.03). Conclusion: We have shown that damage to the mucosal epithelial lining increases a women's risk of HIV seroconversion. Future studies that provide an in depth understanding of the mechanisms associated with the FGT and mucosal immunity will be most valuable. An understanding of all of these mechanisms will be key in directing the advancement of products most suitable for combating HIV infection in women.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Inhibitory Control Predicts Growth in Irregular Word Reading: Evidence From a Large-Scale Longitudinal Study
    Qiu, Yani
    Griffiths, Sarah
    Norbury, Courtenay
    Taylor, J. S. H.
    DEVELOPMENTAL PSYCHOLOGY, 2023, 59 (12) : 2367 - 2378
  • [22] Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial
    Bhattacharya, Romit
    Uddin, Md Mesbah
    Patel, Aniruddh P.
    Niroula, Abhishek
    Finneran, Phoebe
    Bernardo, Rachel
    Fitch, Kathleen V.
    Lu, Michael T.
    Bloomfield, Gerald S.
    Malvestutto, Carlos
    Aberg, Judy A.
    Fichtenbaum, Carl J.
    Hornsby, Whitney
    Ribaudo, Heather J.
    Libby, Peter
    Ebert, Benjamin L.
    Zanni, Markella V.
    Douglas, Pamela S.
    Grinspoon, Steven K.
    Natarajan, Pradeep
    BLOOD ADVANCES, 2024, 8 (04) : 959 - 967
  • [23] Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designs
    Fadoukhair, Z.
    Zardavas, D.
    Chad, M. A.
    Goulioti, T.
    Aftimos, P.
    Piccart, M.
    ONCOGENE, 2016, 35 (14) : 1743 - 1749
  • [24] Risk Factors for High-Risk Human Papillomavirus Detection Among HIV-Negative and HIV-Positive Women From Tanzania
    Dartell, Myassa
    Rasch, Vibeke
    Munk, Christian
    Kahesa, Crispin
    Mwaiselage, Julius
    Iftner, Thomas
    Kjaer, Susanne Kruger
    SEXUALLY TRANSMITTED DISEASES, 2013, 40 (09) : 737 - 743
  • [25] Clinical implications of AGR2 in primary prostate cancer: Results from a large-scale study
    Wambach, Moritz
    Montani, Matteo
    Runz, Josefine
    Stephan, Carsten
    Jung, Klaus
    Moch, Holger
    Eberli, Daniel
    Bernhardt, Marit
    Hommerding, Oliver
    Kreft, Tobias
    Cronauer, Marcus V.
    Kremer, Anika
    Mayr, Thomas
    Hauser, Stefan
    Kristiansen, Glen
    APMIS, 2024, 132 (04) : 256 - 266
  • [26] Appraising the causal effects of circulating micronutrients on liver cirrhosis: Evidence from large-scale Mendelian randomization analysis
    Lin, Junlong
    Chen, Jialin
    Li, Zhichao
    Qian, Baifeng
    Hua, Yunpeng
    PORTAL HYPERTENSION & CIRRHOSIS, 2024, 3 (03): : 160 - 170
  • [27] Technology management practices and innovation: Empirical evidence from medium- and large-scale manufacturing firms in Ethiopia
    Kalko, Mesfin Mala
    Erena, Obsa Teferi
    Debele, Sara Adugna
    AFRICAN JOURNAL OF SCIENCE TECHNOLOGY INNOVATION & DEVELOPMENT, 2023, 15 (01) : 107 - 123
  • [28] Randomised clinical trial using Coronary Artery Calcium Scoring in Australian Women with Novel Cardiovascular Risk Factors (CAC-WOMEN Trial): study protocol
    Marschner, Simone
    Wing-Lun, Edwina
    Chow, Clara
    Maple-Brown, Louise
    Graham, Sian
    Nicholls, Stephen J.
    Brown, Alex
    Wood, Anna
    Ihdayhid, Abdul
    Von Huben, Amy
    Zaman, Sarah
    BMJ OPEN, 2022, 12 (12):
  • [29] Natural killer cell function in women at high risk for HIV acquisition: insights from a microbicide trial
    Naranbhai, Vivek
    Altfeld, Marcus
    Karim, Quarraisha Abdool
    Ndung'u, Thumbi
    Karim, Salim S. Abdool
    Carr, William H.
    AIDS, 2012, 26 (14) : 1745 - 1753
  • [30] Identification of risk factors for elevated serum IgG4 levels in subjects in a large-scale health checkup cohort study
    Tsuji, Yoshika
    Koga, Tomohiro
    Nonaka, Fumiaki
    Nobusue, Kenichi
    Kawashiri, Shin-ya
    Yamanashi, Hirotomo
    Maeda, Takahiro
    Arima, Kazuhiko
    Aoyagi, Kiyoshi
    Takahashi, Meiko
    Kawaguchi, Shuji
    Matsuda, Fumihiko
    Fujii, Hiroshi
    Kawano, Mitsuhiro
    Nakamura, Hiroyuki
    Kawakami, Atsushi
    Tamai, Mami
    FRONTIERS IN IMMUNOLOGY, 2023, 14